Literature DB >> 26356527

[Oxidative stress and Parkinson's disease: mechanisms and perspectives of treatment].

E A Katunina1, N V Titova1, E A Malykhina1, M G Gasanov1, A A Makarova1, T A Voronina2, L N Nerobkova2, E A Valdman2, G N Avakyan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26356527     DOI: 10.17116/jnevro201511571141-145

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


× No keyword cloud information.
  1 in total

1.  Tectorigenin attenuates the MPP+-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson's disease by oxidative stress inhibition.

Authors:  Ping Gong; Fang Deng; Wei Zhang; Jin Ji; Jia Liu; Yinan Sun; Jiayu Hu
Journal:  Exp Ther Med       Date:  2017-08-28       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.